8895546

2 known cases. View patent page →

Cases
2
Active
2
0 closed
Filed
2024–2025
Top venue
D. Delaware
1 case

Neurelis, Inc. v. Padagis LLC et al.

pending
Docket:
1:24-cv-00562-MN
Filed:
2024-05-08

ANDA/Hatch-Waxman litigation over Padagis ANDA No. 219320 for generic diazepam nasal spray. It is the lead consolidated action and asserts the '414 patent along with related family patents. Trial is scheduled as a bench trial beginning March 1, 2027.

Padagis US LLC v. Neurelis, Inc.

active
Docket:
IPR2025-00464
Filed:
2025-01-17
Patents:8895546

Inter partes review challenging claims 1-22 of the '546 patent. The Board instituted review on September 16, 2025. Neurelis filed a statutory disclaimer disclaiming claims 1-16 and 18-21, leaving claims 17 and 22 at issue, and no Final Written Decision has yet issued.